Christopher Sullivan

Insider Reports History

Location
Baltimore, MD
Signature
/s/ Christopher Sullivan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Sullivan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Avalo Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 48,400 $409,464 $8.46 28 Mar 2025 Direct
Avalo Therapeutics, Inc. Chief Financial Officer Common Stock 17,338 $71,085 $4.1 10 Dec 2025 Direct
Avalo Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 163,000 28 Jan 2025 Direct

Insider Reports Filed by Christopher Sullivan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVTX Avalo Therapeutics, Inc. 10 Dec 2025 1 -$635 4 Chief Financial Officer 12 Dec 2025, 16:17
AVTX Avalo Therapeutics, Inc. 28 Mar 2025 3 -$61,631 4 Chief Financial Officer 01 Apr 2025, 16:11
AVTX Avalo Therapeutics, Inc. 28 Jan 2025 1 $0 4 Chief Financial Officer 30 Jan 2025, 17:43
AVTX Avalo Therapeutics, Inc. 13 Aug 2024 2 $0 4 Chief Financial Officer 14 Aug 2024, 16:11
AVTX Avalo Therapeutics, Inc. 09 Jun 2023 1 $1,747 4 Chief Financial Officer 13 Jun 2023, 16:41
AVTX Avalo Therapeutics, Inc. 15 May 2023 1 $0 4 Chief Financial Officer 17 May 2023, 07:44
AVTX Avalo Therapeutics, Inc. 13 Feb 2023 1 $0 4 Chief Financial Officer 15 Feb 2023, 15:19
AVTX Avalo Therapeutics, Inc. 05 Oct 2022 1 $0 4 Chief Financial Officer 07 Oct 2022, 16:01
AVTX Avalo Therapeutics, Inc. 08 Mar 2022 2 $0 4 Chief Financial Officer 10 Mar 2022, 16:50
AVTX Avalo Therapeutics, Inc. 10 Dec 2021 1 $1,499 4 Chief Accounting Officer 14 Dec 2021, 16:17